LQDA
LQDA
NASDAQ · Pharmaceuticals

Liquidia Corp

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$70.95
+3.46 (+5.13%)
As of Sep 24, 9:57 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 11 73%
Hold 4 27%
Sell 0 0%
Price Target
Analyst Price Target -39.2% upside
Low Target $30.71
Average Target $43.17
High Target $51.56
Current Price $70.95
Current
$70.95
Target
$43.17
$30.71 $43.17 avg $51.56
Scenario Analysis
Bear Case
$30.71
-56.7%
Low target
Base Case
$43.17
-39.2%
Avg target
Bull Case
$51.56
+-27.3%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$93.61
-24.2% from high
52-Week Low
$21.15
+235.5% from low
50-Day SMA
$37.31
+90.2% vs SMA
200-Day SMA
$25.48
+178.5% vs SMA
RSI (14)
31.7
Neutral
Target vs 52W High
$43.17
-53.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.6%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +10.7%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +19.3%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +183.7%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -37.8%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +198.7%